Is PCDC (platelet-derived cell derivative) injection a suitable treatment option for a patient seeking facial rejuvenation with Morpheus8, considering their medical history and potential risks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PCDC Injections: Critical Safety Warning

PCDC (phosphatidylcholine/deoxycholate) injections are NOT appropriate for facial rejuvenation and should be avoided in this context—the evidence provided discusses only autologous platelet concentrates (PRP/PRF), which are entirely different substances with established safety profiles for facial use.

Critical Distinction: PCDC vs. Autologous Platelet Concentrates

You appear to be confusing PCDC with platelet-derived concentrates (PRP/PRF). These are fundamentally different:

  • PCDC is a lipolytic agent containing phosphatidylcholine and deoxycholate, FDA-approved only for submental fat reduction (under the chin), not for facial rejuvenation 1
  • Autologous Platelet Concentrates (APCs) including PRP and PRF are derived from the patient's own blood and are used for regenerative facial rejuvenation 2

If You Mean Autologous Platelet Concentrates (PRP/PRF)

For patients seeking facial rejuvenation with Morpheus8, combining the procedure with PRP or PRF is safe and can enhance outcomes through synergistic regenerative effects. 2

Evidence-Based Recommendations for APCs with Morpheus8

Combination therapy with microneedling devices (like Morpheus8) and autologous platelet concentrates demonstrates superior outcomes compared to either modality alone:

  • Microneedling combined with PRP/PRF shows statistically significant increases in epidermal thickness and improved dermal structures compared to microneedling alone 2
  • APCs offer superior biocompatibility and reduce risks of adverse effects and vascular occlusions compared to traditional fillers 3
  • The treatment is safe across all skin types with minimal side effects 4, 5

Treatment Protocol

Standard protocol for combining APCs with radiofrequency microneedling:

  • Three treatment sessions spaced at minimum 21-day intervals 6
  • Maintenance treatments every 6 months thereafter 6, 3
  • APCs can be applied topically during Morpheus8 treatment or injected intradermally immediately after 2
  • Use 30-gauge needles for intradermal injection to minimize trauma 3

Expected Outcomes

Patients can expect improvements in:

  • Skin texture, tone, and elasticity with over 2-fold improvement in collagen synthesis 3
  • Wrinkles, fine lines, and skin roughness 2
  • Skin thickness and hydration 2
  • Overall facial appearance with high patient satisfaction rates (average 4.4/5) 2

Safety Profile

APCs demonstrate excellent safety as autologous materials:

  • Minimal side effects limited to mild pain, temporary bruising, or swelling 2, 6
  • No risk of allergic reactions since derived from patient's own blood 3
  • Significantly lower vascular occlusion risk compared to hyaluronic acid fillers 3
  • No cases of hyperpigmentation, hypopigmentation, or scarring reported with proper technique 5

Critical Safety Considerations

Avoid permanent or semi-permanent fillers in combination with energy-based devices:

  • Permanent fillers (polymethylmethacrylate, silicone) should be used with "utmost reticence" and only in reconstructive procedures due to foreign body reaction risks 7
  • Heat from radiofrequency can potentially interact unpredictably with synthetic fillers 7

If You Actually Mean PCDC (Deoxycholic Acid)

Do not use PCDC for facial rejuvenation beyond submental fat reduction:

  • Deoxycholic acid is FDA-approved only for submental fat and has not been studied in other facial areas 1
  • Using lipolytic agents in areas with minimal fat (like most facial rejuvenation zones) risks tissue damage and contour irregularities
  • There is no evidence supporting PCDC use in combination with Morpheus8

Patient Counseling

Advise patients to:

  • Maintain good home skincare and adequate sun protection to enhance results 6
  • Expect temporary bruising and swelling that resolves within days 2, 6
  • Understand that volumizing effects from APCs last 3-4 months, requiring maintenance treatments 3
  • Avoid aspirin and NSAIDs for 7 days before treatment to minimize bruising risk

References

1
Research

Evidence-Based Medicine for Nonsurgical Facial Rejuvenation.

Facial plastic surgery : FPS, 2023

2
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Guideline

Dermal Fillers and Tissue Aging

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6
Guideline

Safety and Efficacy of Platelet-Rich Fibrin for Periorbital Rejuvenation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7
Research

Surgery for foreign body reactions due to injectable fillers.

Dermatology (Basel, Switzerland), 2006

Related Questions

Should I do radio frequency (RF) microneedling or Erbium laser first?
What are the optimal settings for Morpheus 8 (microneedling device) treatment in patients undergoing facial rejuvenation?
Do psychiatric drugs interact with Morpheus8 (microneedling and radiofrequency) treatments?
What is the recommended treatment protocol for a patient seeking facial rejuvenation with Morpheus 8, considering potential contraindications such as pregnancy, breastfeeding, or a history of keloid scarring?
What to do for a facial burn caused by Morpheus8 (microneedling device)?
What is the recommended timing for the next dose of the Men B vaccine for a baby in the UK who has already received the first dose according to the NHS schedule?
What is the recommended treatment protocol for a patient seeking facial rejuvenation with Morpheus 8, considering potential contraindications such as pregnancy, breastfeeding, or a history of keloid scarring?
What is the imaging modality of choice for a patient presenting with symptoms of a cerebrovascular accident (CVA) and hemiplegia 12 hours ago, between Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scan?
What is the composition and administration location of the Men B (Meningococcal group B) vaccine, specifically Bexsero (Meningococcal B vaccine), used in the NHS UK for infant vaccines?
Can Men B (Meningococcal B) vaccines be interchanged?
What are the guidelines and safety considerations for using deoxycholic acid injections for facial rejuvenation and submental fat reduction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question